Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients

被引:31
作者
Ajeganova, Sofia [1 ,2 ]
Gustafsson, Thomas [3 ,4 ]
Lindberg, Linnea [3 ,4 ]
Hafstrom, Ingiald [1 ]
Frostegard, Johan [5 ]
机构
[1] Karolinska Inst, Div Gastroenterol & Rheumatol, Dept Med Huddinge, Stockholm, Sweden
[2] Vrije Univ Brussel, Div Rheumatol, Clin Sci, Brussels, Belgium
[3] Karolinska Univ Hosp, Div Clin Physiol, Dept Lab Med, Stockholm, Sweden
[4] Karolinska Univ Hosp, Unit Clin Physiol, Stockholm, Sweden
[5] Karolinska Inst, Inst Environm Med, Sect Immunol & Chron Dis, Stockholm, Sweden
关键词
SUBCLINICAL ATHEROSCLEROSIS; RISK-FACTORS; CARDIOVASCULAR EVENTS; DENSITY-LIPOPROTEIN; ERYTHEMATOSUS; WOMEN; PREVALENCE; PLAQUE; PREMENOPAUSAL; COHORT;
D O I
10.1136/lupus-2019-000362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To compare progression of subclinical atherosclerosis and factors promoting it in patients with SLE and controls. Methods Consecutive patients with SLE and age-matched, sex-matched population controls from the SLEVIC cohort were assessed at inclusion and after 7 years with standardised data collection and carotid ultrasound. Effect of risk factors on carotid intima-media thickness (cIMT) progression was examined with adjusted linear mixed models. Results A total of 77 patients and 74 controls, 68% and 61% of the original cohort, completed follow-up. The patients were (mean) 47 years old, 90% were women, and controls were 51 years old, 92% women. Patients had disease duration of (mean) 11 years, mild disease activity and low severity at both assessments. Baseline cIMT did not differ between the groups. An average absolute cIMT progression was 0.009 mm/year in patients and 0.011 mm/year in controls, intergroup difference p=0.9. Of factors at inclusion, dyslipidaemia, lower levels of high-density lipoprotein (HDL) and carotid plaque in patients and controls, and higher systolic blood pressure, total cholesterol:HDL and LDL:HDL ratios and triglycerides in patients were associated with cIMT progression. Of factors at follow-up, hypertension and blood lipids in patients and HDL in controls were significantly associated with cIMT progression. History of lupus nephritis and a higher average dose of prednisolone used since diagnosis were associated with cIMT progression in patients. Associations of risk factors with cIMT progression were stronger in presence of plaques. Conclusion We observed a statistically comparable progression of cIMT in patients with mild SLE and controls over 7 years, which implies that progression of subclinical atherosclerosis in some patients with SLE could follow that of the general population. Traditional cardiovascular (CV) risk factors, history of lupus nephritis and higher use of corticosteroids promote cIMT progression in SLE. Detection of carotid plaque may add to CV risk stratification.
引用
收藏
页数:11
相关论文
共 48 条
[1]   Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus [J].
Anania, Cristina ;
Gustafsson, Thomas ;
Hua, Xiang ;
Su, Jun ;
Vikstrom, Max ;
de Faire, Ulf ;
Heimburger, Mikael ;
Jogestrand, Tomas ;
Frostegard, Johan .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (06)
[2]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[3]   The global burden of SLE: prevalence, health disparities and socioeconomic impact [J].
Carter, Erin E. ;
Barr, Susan G. ;
Clarke, Ann E. .
NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (10) :605-620
[4]   High-Density Lipoprotein Infusion Therapy and Atherosclerosis Current Research and Future Directions [J].
Chen, Nan ;
Frishman, William H. .
CARDIOLOGY IN REVIEW, 2016, 24 (06) :298-302
[5]   Human low-affinity IgG receptor FcRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus [J].
Clancy, Robert ;
El Bannoudi, Hanane ;
Rasmussen, Sara E. ;
Bornkamp, Nicole ;
Allen, Nicole ;
Dann, Rebecca ;
Reynolds, Harmony ;
Buyon, Jill P. ;
Berger, Jeffrey S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (03) :532-537
[6]   Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus [J].
de Leeuw, Karina ;
Smit, Andries J. ;
de Groot, Eric ;
van Roon, Arie M. ;
Kallenberg, Cees G. ;
Bijl, Marc .
ATHEROSCLEROSIS, 2009, 206 (02) :546-550
[7]   Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study [J].
Di Minno, Matteo Nicola Dario ;
Emmi, Giacomo ;
Ambrosino, Pasquale ;
Scalera, Antonella ;
Tufano, Antonella ;
Cafaro, Giovanni ;
Peluso, Rosario ;
Bettiol, Alessandra ;
Di Scala, Gerardo ;
Silvestri, Elena ;
Prisco, Domenico .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 274 :1-6
[8]   Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort The PESA (Progression of Early Subclinical Atherosclerosis) Study [J].
Fernandez-Friera, Leticia ;
Penalvo, Jose L. ;
Fernandez-Ortiz, Antonio ;
Ibanez, Borja ;
Lopez-Melgar, Beatriz ;
Laclaustra, Martin ;
Oliva, Belen ;
Mocoroa, Agustin ;
Mendiguren, Jose ;
Martinez de Vega, Vicente ;
Garcia, Laura ;
Molina, Jesus ;
Sanchez-Gonzalez, Javier ;
Guzman, Gabriela ;
Alonso-Farto, Juan C. ;
Guallar, Eliseo ;
Civeira, Fernando ;
Sillesen, Henrik ;
Pocock, Stuart ;
Ordovas, Jose M. ;
Sanz, Gines ;
Jesus Jimenez-Borreguero, Luis ;
Fuster, Valentin .
CIRCULATION, 2015, 131 (24) :2104-2113
[9]   Cytokine expression in advanced human atherosclerotic plaques:: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines [J].
Frostegård, J ;
Ulfgren, AK ;
Nyberg, P ;
Hedin, U ;
Swedenborg, J ;
Andersson, U ;
Hansson, GK .
ATHEROSCLEROSIS, 1999, 145 (01) :33-43
[10]   Autoantibody profiling reveals four protein candidate autoantigens associated with systemic lupus erythematosus [J].
Frostegard, J. ;
Hellstrom, C. ;
Nilsson, P. ;
Frostegard, A. G. ;
Ajeganova, S. .
LUPUS, 2018, 27 (10) :1670-1678